tiprankstipranks
Trial Holdings Inc. (JP:141A)
:141A
Japanese Market

Trial Holdings Inc. (141A) AI Stock Analysis

2 Followers

Top Page

JP:141A

Trial Holdings Inc.

(141A)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
¥4,185.00
▲(35.00% Upside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by the sharp 2025 cash-flow reversal (negative operating and free cash flow), despite healthy revenue growth, improved profitability, and a generally reasonable balance sheet. Technical indicators are moderately constructive, while valuation is neutral with a low dividend yield.
Positive Factors
Strong revenue growth
Consistent, high single‑digit to double‑digit revenue expansion (c.42% reported growth) demonstrates durable top‑line momentum and expanding customer reach in the discount retail segment. Scale gains should support purchasing power, SKU economics and reinvestment capacity, sustaining revenue resilience over the medium term.
Negative Factors
Sharp 2025 cash‑flow reversal
The 2025 swing to negative operating cash flow and deeply negative free cash flow marks a material deterioration in cash conversion versus 2024. This raises persistent funding and liquidity risk, suggests working‑capital or capex pressure, and increases dependence on external financing until cash generation normalizes.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Consistent, high single‑digit to double‑digit revenue expansion (c.42% reported growth) demonstrates durable top‑line momentum and expanding customer reach in the discount retail segment. Scale gains should support purchasing power, SKU economics and reinvestment capacity, sustaining revenue resilience over the medium term.
Read all positive factors

Trial Holdings Inc. (141A) vs. iShares MSCI Japan ETF (EWJ)

Trial Holdings Inc. Business Overview & Revenue Model

Company Description
Trial Holdings Inc. operates in the retail, logistics, financial / payment services, and retail tech businesses. The company operates discount-based stores that provide food, living ware, and home appliances. It also offers various solutions utili...

Trial Holdings Inc. Financial Statement Overview

Summary
Income statement and balance sheet are solid (revenue growth and improved profitability; moderate leverage and stronger equity base), but 2025 cash flow deterioration is severe (negative operating cash flow and deeply negative free cash flow), indicating weak earnings-to-cash conversion and higher funding risk.
Income Statement
72
Positive
Balance Sheet
74
Positive
Cash Flow
38
Negative
BreakdownJun 2024Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue806.59B720.44B655.48B597.69B157.93B
Gross Profit155.13B134.00B117.53B103.49B26.32B
EBITDA34.94B31.16B24.81B21.46B4.92B
Net Income11.75B11.44B8.09B7.13B1.85B
Balance Sheet
Total Assets300.28B283.63B200.64B185.73B171.44B
Cash, Cash Equivalents and Short-Term Investments72.33B91.95B23.90B27.43B22.74B
Total Debt38.56B16.16B19.61B24.44B27.94B
Total Liabilities171.25B165.44B132.62B126.02B118.65B
Stockholders Equity126.13B115.68B65.89B57.96B51.47B
Cash Flow
Free Cash Flow-38.41B36.90B2.55B10.01B-7.10B
Operating Cash Flow-4.45B59.50B18.45B22.34B-2.94B
Investing Cash Flow-35.89B-26.00B-16.77B-13.49B-4.72B
Financing Cash Flow20.77B34.50B-5.19B-4.32B-1.34B

Trial Holdings Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3100.00
Price Trends
50DMA
3762.88
Positive
100DMA
3213.58
Positive
200DMA
2788.62
Positive
Market Momentum
MACD
101.06
Positive
RSI
54.10
Neutral
STOCH
40.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:141A, the sentiment is Positive. The current price of 3100 is below the 20-day moving average (MA) of 4098.75, below the 50-day MA of 3762.88, and above the 200-day MA of 2788.62, indicating a bullish trend. The MACD of 101.06 indicates Positive momentum. The RSI at 54.10 is Neutral, neither overbought nor oversold. The STOCH value of 40.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:141A.

Trial Holdings Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥115.04B16.521.92%2.30%26.52%
76
Outperform
¥155.66B15.861.64%10.13%23.77%
72
Outperform
¥218.03B15.192.43%4.48%13.17%
68
Neutral
¥3.11T19.7516.37%0.73%6.23%16.45%
66
Neutral
¥293.19B2.684.97%2.01%2.00%-68.35%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
¥516.03B18.820.56%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:141A
Trial Holdings Inc.
4,205.00
1,982.38
89.19%
JP:7532
Pan Pacific International Holdings
991.90
168.90
20.52%
JP:8242
H2O Retailing Corporation
2,403.50
192.72
8.72%
JP:8194
Life Corporation
2,520.00
610.31
31.96%
JP:8198
Maxvalu Tokai Co., Ltd.
3,615.00
702.90
24.14%
JP:9974
BELC Co., Ltd.
7,460.00
808.84
12.16%

Trial Holdings Inc. Corporate Events

Trial Holdings lifts sales on private-brand push and store expansion in early 2026
Mar 10, 2026
Trial Holdings reported steady year-on-year sales growth at both comparable and all stores for early 2026, driven by higher average spending despite softer customer traffic. The company continues to expand its footprint, opening four new stores in...
TRIAL Holdings Sets Medium-Term Plan to Integrate SEIYU and Advance Tech-Driven Retail
Feb 12, 2026
TRIAL Holdings has unveiled a medium-term management plan covering fiscal years 2027 to 2029 aimed at revolutionizing real-world commerce through technology and practical know-how. The strategy consolidates TRIAL and SEIYU operations under a group...
Trial Holdings outlines 1H FY2026 results and strategic direction
Feb 12, 2026
Trial Holdings, Inc. has released a financial results presentation for the first half of its fiscal year ending June 2026, covering the period from July 1 to December 31, 2025. The materials outline the company’s operating performance, its i...
TRIAL Holdings Posts Surging Sales but Profit Drops Amid Aggressive Expansion
Feb 12, 2026
TRIAL Holdings reported a sharp rise in net sales to ¥674.1 billion for the six months ended Dec. 31, 2025, up 67.0% year on year, with EBITDA more than doubling and operating profit climbing 71.9%. Despite this top-line strength, profit attr...
Trial Holdings Starts 2026 With Strong New Year Sales and Reporting Shift for SEIYU Stores
Feb 10, 2026
Trial Holdings reported solid year-on-year growth in January 2026, with all-store sales up more than 10%, supported by higher average spending despite flat customer traffic. Demand for winter seasonal items and strong New Year trading, including l...
TRIAL Holdings Grows Sales and Store Network on Strong Food Demand Despite Mild Winter
Jan 9, 2026
TRIAL Holdings reported continued year-on-year sales growth in its retail operations for the latest reported months, with all-store sales up around 10% and comp-store sales modestly higher despite softer customer traffic, supported by increased av...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026